Compound ID | 2229
Class: Drug efflux pump inhibitor
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Efflux pump inhibitor. Targets the AcrB component of the AcrAB-TolC transporter |
| Target Pathogen: | Active against Escherichia coli |
| Propensity to select resistant mutants: | Yes |
| Description: | Synthetic compound (pyridylpiperazine); identified from screening assay that synergised activity of pyridomycin; also acts synergistically with chloramphenicol, tetracycline, pyridomycin, erythromycin, and ciprofloxacin; no cytotoxicity towards BALB/3T3 |
| Year first mentioned: | 2022 |
| Development status: | Experimental |
| External links: | |
| Citations: |
|